APA (7th ed.) Citation

Consortium, T. T., Benator, D., Bhattacharya, M., Bozeman, L., Burman, W., Cantazaro, A., . . . Weis, S. (2002). Rifapentine and isoniazid once a week versus rifampicin and isoniazid twice a week for treatment of drug-susceptible pulmonary tuberculosis in HIV-negative patients: A randomised clinical trial. Lancet, 360(9332), 528. https://doi.org/10.1016/s0140-6736(02)09742-8

Chicago Style (17th ed.) Citation

Consortium, Tuberculosis Trials, et al. "Rifapentine and Isoniazid Once a Week Versus Rifampicin and Isoniazid Twice a Week for Treatment of Drug-susceptible Pulmonary Tuberculosis in HIV-negative Patients: A Randomised Clinical Trial." Lancet 360, no. 9332 (2002): 528. https://doi.org/10.1016/s0140-6736(02)09742-8.

MLA (9th ed.) Citation

Consortium, Tuberculosis Trials, et al. "Rifapentine and Isoniazid Once a Week Versus Rifampicin and Isoniazid Twice a Week for Treatment of Drug-susceptible Pulmonary Tuberculosis in HIV-negative Patients: A Randomised Clinical Trial." Lancet, vol. 360, no. 9332, 2002, p. 528, https://doi.org/10.1016/s0140-6736(02)09742-8.